| NP0351338 | Sarcglabtene I | |  | C32H38O8
550.6480 Da 550.25667 Da | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0351337 | Sarcglabtene H | |  | C48H54O12
822.9480 Da 822.36153 Da | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0351336 | Sarcglabtene G | |  | C25H32O4
396.5270 Da 396.23006 Da | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0351335 | Sarcglabtene F | |  | C25H32O4
396.5270 Da 396.23006 Da | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0351334 | Sarcglabtene E | |  | C30H36O5
476.6130 Da 476.25627 Da | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0351333 | Sarcglabtene D | |  | C59H74O10
943.2310 Da 942.52820 Da | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0351332 | Sarcglabtene C | |  | C59H74O10
943.2310 Da 942.52820 Da | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0351331 | Sarcglabtene B | |  | C51H60O12
865.0290 Da 864.40848 Da | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0351330 | Sarcglabtene A | |  | C51H60O12
865.0290 Da 864.40848 Da | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) |
|
| NP0351329 | fortlipoamide A, hydrolyzed LP 4 | |  | C33H62N4O6
610.8810 Da 610.46694 Da | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0351328 | fortcupinile A, INLP 3 | |  | C33H58N4O4
574.8510 Da 574.44581 Da | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0351327 | MC-602 | |  | C32H47N3O8
601.7410 Da 601.33632 Da | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 226 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 900 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) |
|
| NP0351326 | MC-586 | |  | C32H48N3O7
586.7490 Da 586.34868 Da | | 13C NMR Spectrum (1D, 226 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 900 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) |
|
| NP0351325 | MC-584b | |  | C32H46N3O7
584.7330 Da 584.33303 Da | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 900 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) |
|
| NP0351324 | MC-584a | |  | C32H45N3O7
583.7260 Da 583.32575 Da | | 1H NMR Spectrum (1D, 900 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 226 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C2D6OS, experimental) |
|
| NP0351323 | Purpurinidin | |  | C41H41O20
853.7580 Da 853.21857 Da | | 13C NMR Spectrum (1D, 151.0, CD3OD/TFA-d1 (95/5) , simulated) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0351322 | D-Histidine | |  | C6H9N3O2
155.1570 Da 155.06948 Da | | 1H NMR Spectrum (1D, 600.0, C2D6OS, simulated) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0351320 | 9-O-α-D-glucose-aspyranochromenone A | |  | C23H26O12
494.4490 Da 494.14243 Da | | 1H NMR Spectrum (1D, 700.0, C2D6OS, simulated) | | 13C NMR Spectrum (1D, 175.0, C2D6OS, simulated) | | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) |
|
| NP0351319 | Lactamide | |  | C3H7NO2
89.0940 Da 89.04768 Da | | 1H NMR Spectrum (1D, 600.0, D2O, simulated) | | 1H NMR Spectrum (1D, 600 MHz, D2O, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, D2O, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, D2O, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, D2O, experimental) |
|
| NP0351316 | Tryptophol | |  | C10H11NO
161.2004 Da 161.08406 Da | | 1H NMR Spectrum (1D, 600.0, C2D6OS, simulated) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
| NP0351311 | 7-Hydroxy-3(4'-methoxyphenyl)-coumarin | |  | C16H12O4
268.2680 Da 268.07356 Da | |
| NP0351310 | 3-hydroxymethyl conopharyngine | |  | C24H32N2O5
428.5290 Da 428.23112 Da | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0351309 | 6-oxoconopharyngine | |  | C23H28N2O5
412.4860 Da 412.19982 Da | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) |
|
| NP0351300 | Scleroderolide | |  | C18H16O6
328.3200 Da 328.09469 Da | |
| NP0351299 | (+)-Aceatrovenetinone B | |  | C22H22O7
398.4110 Da 398.13655 Da | |